Inventor · disambiguated record
John Eric Paderi
Also filed as: PADERI JOHN · PADERI JOHN E · PADERI JOHN ERIC
14 granted patents·38 pending applications·235 citations·filing 2009–2025
93Inventor score
Top patents by PatentIndex Score
52 records- 0196US10625074B2Devices and methods for controlling tremorCALA HEALTH INC·Filed 2018·Granted Apr 21, 2020·45 cites·19 claims
- 0295US9452287B2Devices and methods for controlling tremorROSENBLUTH KATHRYN H·Filed 2015·Granted Sep 27, 2016·114 cites·27 claims
- 0394US12161858B2Devices and methods for controlling tremorCALA HEALTH INC·Filed 2020·Granted Dec 10, 2024·3 cites·21 claims
- 0494US10850090B2Devices and methods for controlling tremorCALA HEALTH INC·Filed 2016·Granted Dec 1, 2020·20 cites·15 claims
- 0589US2025345594A1Separable housing for tremor reduction systemCALA HEALTH INC·Filed 2025·Application pending·0 cites
- 0689US2025339672A1Tremor reduction using cloud computingCALA HEALTH INC·Filed 2025·Application pending·0 cites
- 0789US2025339671A1Tailored nerve stimulation for tremorCALA HEALTH INC·Filed 2025·Application pending·0 cites
- 0889US2025345593A1Tremor reduction using machine learning algorithmsCALA HEALTH INC·Filed 2025·Application pending·0 cites
- 0987US8846003B2Collagen-binding synthetic peptidoglycans, preparation, and methods of usePANITCH ALYSSA·Filed 2009·Granted Sep 30, 2014·9 cites·16 claims
- 1086US9512192B2Collagen-binding synthetic peptidoglycans, preparation, and methods of usePURDUE RESEARCH FOUNDATION·Filed 2016·Granted Dec 6, 2016·5 cites·13 claims
- 1186US9217016B2Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of usePANITCH ALYSSA·Filed 2012·Granted Dec 22, 2015·12 cites·17 claims
- 1286US9200039B2Extracellular matrix-binding synthetic peptidoglycansSYMIC BIOMEDICAL INC·Filed 2014·Granted Dec 1, 2015·16 cites·29 claims
- 1385US9173919B2Collagen-targeted nanoparticlesPADERI JOHN E·Filed 2012·Granted Nov 3, 2015·6 cites·18 claims
- 1480US9872887B2Extracellular matrix-binding synthetic peptidoglycansPURDUE RESEARCH FOUNDATION·Filed 2015·Granted Jan 23, 2018·3 cites·23 claims
- 1579US10689425B2Collagen-binding synthetic peptidoglycans, preparation, and methods of usePURDUE RESEARCH FOUNDATION·Filed 2016·Granted Jun 23, 2020·2 cites·16 claims
- 1678US2025161663A1Devices and methods for controlling tremorCALA HEALTH INC·Filed 2025·Application pending·0 cites
- 1775US2023390466A1Systems and methods for optimizing treatment using physiological profilesDEXCOM INC·Filed 2023·Application pending·0 cites
- 1874US2023389844A1Sensing systems and methods for diagnosing kidney diseaseDEXCOM INC·Filed 2023·Application pending·0 cites
- 1974US2023389833A1Systems and methods for monitoring, diagnosis, and decision support for diabetes in patients with kidney diseaseDEXCOM INC·Filed 2023·Application pending·0 cites
- 2067US2022313830A1Heparin-peptide bioconjugates and uses thereofSYMIC HOLDINGS USA INC·Filed 2022·Application pending·0 cites
- 2165US2021188915A1Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of useSymic OA ApS·Filed 2020·Application pending·0 cites
- 2265US2025213151A1Systems and methods for providing therapy management guidance related to liver disease decompensation to users with liver diseaseDEXCOM INC·Filed 2024·Application pending·0 cites
- 2364US2025049355A1Systems and methods for providing therapy management recommendations for diabetic patients and patients with liver diseaseDEXCOM INC·Filed 2024·Application pending·0 cites
- 2461US2025353936A1Chemically modified heparinIHP THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2561US2025360161A1Chemically modified heparinIHP THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2659US2024342556A1Sensing systems and methods for providing optimized exercise guidance to healthy hosts and athletes using continuously monitored analyte dataDEXCOM INC·Filed 2024·Application pending·0 cites
- 2759US2024342555A1Sensing systems and methods for providing optimized exercise guidance to metabolically unfit hosts using continuously monitored analyte dataDEXCOM INC·Filed 2024·Application pending·0 cites
- 2858US2015038425A1Collagen-binding synthetic peptidoglycans for use in vascular interventionSYMIC BIOMEDICAL INC·Filed 2014·Application pending·0 cites
- 2958US2023263434A1Sensing systems and methods for providing decision support around kidney health and/or diabetesDEXCOM INC·Filed 2023·Application pending·0 cites
- 3058US2015038427A1Collagen-binding synthetic peptidoglycans for wound healingSYMIC BIOMEDICAL INC·Filed 2014·Application pending·0 cites
- 3158US2025311973A1Systems and methods for providing therapy management guidance to patients to optimize glp-1 therapy effectivenessDEXCOM INC·Filed 2025·Application pending·0 cites
- 3258US2018030091A1Collagen-binding synthetic peptidoglycans for use in vascular interventionPURDUE RESEARCH FOUNDATION·Filed 2017·Application pending·0 cites
- 3357US2025325206A1Systems and methods for providing therapy management guidance for diagnosis and management of kidney diseaseDEXCOM INC·Filed 2025·Application pending·0 cites
- 3457US2023240589A1Sensing systems and methods for diagnosing, staging, treating, and assessing risks of liver disease using monitored analyte dataDEXCOM INC·Filed 2023·Application pending·0 cites
- 3557US2015031619A1Collagen-binding synthetic peptidoglycans, preparation, and methods of useSYMIC BIOMEDICAL INC·Filed 2014·Application pending·0 cites
- 3656US2023241095A1Partially desulfated heparin for treating coronaviral infectionsIHP THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3756US2012100106A1Collagen-binding synthetic peptidoglycans for wound healingPANITCH ALYSSA·Filed 2010·Application pending·0 cites
- 3856US2019330276A1Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of useSYMIC IP LLC·Filed 2018·Application pending·0 cites
- 3953US2020078469A1Heparin-peptide bioconjugates and uses thereofSYMIC IP LLC·Filed 2019·Application pending·0 cites
- 4053US2016229895A1Collagen-binding synthetic peptidoglycans for use in vascular interventionSYMIC IP LLC·Filed 2016·Application pending·0 cites
- 4153US2019022175A1Extracellular matrix-binding synthetic peptidoglycansPURDUE RESEARCH FOUNDATION·Filed 2017·Application pending·0 cites
- 4253US2017283458A1Collagen-binding synthetic peptidoglycans for wound healingSYMIC BIOMEDICAL INC·Filed 2016·Application pending·0 cites
- 4352US2016166654A1Collagen-targeted nanoparticlesPURDUE RESEARCH FOUNDATION·Filed 2015·Application pending·0 cites
- 4451US12453853B2Multi-modal stimulation for treating tremorCALA HEALTH INC·Filed 2018·Granted Oct 28, 2025·0 cites·18 claims
- 4550US2013190246A1Collagen-binding synthetic peptidoglycans for use in vascular interventionPADERI JOHN E·Filed 2011·Application pending·0 cites
- 4647US2016222064A1Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of useSYMIC IP LLC·Filed 2015·Application pending·0 cites
- 4745US2016331841A1Bioconjugates and uses thereofSYMIC IP LLC·Filed 2016·Application pending·0 cites
- 4843US11896642B2Bioconjugates with chemically modified backbonesSYMIC HOLDINGS INC·Filed 2018·Granted Feb 13, 2024·0 cites·8 claims
- 4943US2014350327A1Device and method for interfering with sympathetic chain signaling for attenuating hot flashes, post-traumatic stress disorder, pain and dysautonomiaUNIV LELAND STANFORD JUNIOR·Filed 2014·Application pending·0 cites
- 5038US2017112941A1Ve-cadherin binding bioconjugateSYMIC IP LLC·Filed 2016·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John Eric Paderi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →